<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Evul Winoto Lukito</style></author><author><style face="normal" font="default" size="100%">Dyah Iswantini</style></author><author><style face="normal" font="default" size="100%">Budhi Antariksa</style></author><author><style face="normal" font="default" size="100%">Mohamad Rafi</style></author><author><style face="normal" font="default" size="100%">Setyanto Tri Wahyudi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Screening and Identification of Metabolites from Sambiloto (Andrographis paniculata) Ethanol Extract for Pro-Inflammatory Cytokines Inhibitory through In Silico and In Vitro Approaches</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">LC-MS/MS</style></keyword><keyword><style  face="normal" font="default" size="100%">Molecular docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Pro-inflammatory cytokines</style></keyword><keyword><style  face="normal" font="default" size="100%">Sambiloto</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">131-140</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Andrographis paniculata has long been a traditional medicinal plant in Indonesia. This study is intended to evaluate the anti-pro-inflammatory cytokines of 98% ethanol extract of A. paniculata by &lt;em&gt;in vitro&lt;/em&gt; and &lt;em&gt;in silico&lt;/em&gt; approaches. Inhibition of pro-inflammatory cytokines is also one of the therapies in treating COVID-19. &lt;strong&gt;Methods: &lt;/strong&gt;The molecular docking approach was utilized as a first screening to evaluate the potential for suppression of macrophage cell activation; an ADMET prediction test was performed to determine the pharmacological, pharmacokinetic, and toxicity as a therapeutic target. TNF-α, IL-1ß, and IL-6 levels were measured using an ELISA method to investigate anti-cytokine pro-inflammatory activity in LPS-induced RAW 264.7 macrophage cells. LC-MS/MS was used to identify additional metabolite compounds. &lt;strong&gt;Results:&lt;/strong&gt; Ethanol extract containing particular metabolites 14-Deoxyandrographoside and 14-Deoxy-17-hydroxyandrographolide inhibited TNF-α and IL-1β by 100% and IL-6 by 85.59%, respectively. While compared to the Dexamethasone molecule as a positive control, preliminary screening and ADMET prediction for the metabolite compound 14-Deoxyandrographoside exhibited relatively high binding stability to the CD14 receptor by -7.5 kcal/mol and was safe against various ADMET indications. &lt;strong&gt;Conclusions: &lt;/strong&gt;This study reveals that the compound 14-Deoxyandrographoside in pure ethanol extract is a potential anticytokine agent candidate for treating pro-inflammatory cytokines, including COVID-19 infection.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">131</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Evul Winoto Lukito&lt;sup&gt;1&lt;/sup&gt;, Dyah Iswantini&lt;sup&gt;1,2&lt;/sup&gt;*, Budhi Antariksa&lt;sup&gt;3&lt;/sup&gt;, Mohamad Rafi&lt;sup&gt;1,2&lt;/sup&gt;, Setyanto Tri Wahyudi&lt;sup&gt;2,4&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Chemistry, Faculty of Mathematics and Natural Sciences, IPB University, Bogor 16680, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Tropical Biopharmaca Research Center, IPB University, Bogor 16128, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Persahabatan Hospital, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Physics, Faculty of Mathematics and Natural Sciences, IPB University, Bogor 16680, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Min Rahminiwati</style></author><author><style face="normal" font="default" size="100%">Rut Novalia Rahmawati Sianipar</style></author><author><style face="normal" font="default" size="100%">Komar Sutriah</style></author><author><style face="normal" font="default" size="100%">Dyah Iswantini</style></author><author><style face="normal" font="default" size="100%">Trivadila</style></author><author><style face="normal" font="default" size="100%">Suminar Setiati Achmadi</style></author><author><style face="normal" font="default" size="100%">Ibnu Hari Sulistyawan</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Optimization of Xanthine Oxidase Activity, Phytochemical Screening, Toxicity Assay, and Antigout Activity of Spatholobus littoralis Hassk. Extract</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Box-Behnken Design</style></keyword><keyword><style  face="normal" font="default" size="100%">Gout</style></keyword><keyword><style  face="normal" font="default" size="100%">Lineweaver-Burk plot</style></keyword><keyword><style  face="normal" font="default" size="100%">Spatholobus littoralis Hassk</style></keyword><keyword><style  face="normal" font="default" size="100%">Xanthine Oxidase.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">258-269</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: A medicinal plant from Central Kalimantan, &lt;em&gt;Spatholobus littoralis &lt;/em&gt;Hassk., with a local name bajakah tampala, has long been used to treat gout or uric acid disease. This study aimed to develop the optimum conditions of xanthine oxidase (XO) activity, phytochemical screening, and to obtain the antigout activity of &lt;em&gt;S. littoralis &lt;/em&gt;Hassk.&lt;strong&gt; Methods:&lt;/strong&gt; Before performing the phytochemical screening, we performed a simplicia maceration with water and 70% ethanol solvents. The development of the optimum conditions for XO was carried out using the Response Surface Methodology (RSM) combined Box-Behnken Design (BBD). Toxicity assay (LC&lt;sub&gt;50&lt;/sub&gt;) on both extracts was assessed by BSLT (Brine Shrimp Lethality Test). The two extracts were then evaluated for antigout activity. &lt;strong&gt;Results:&lt;/strong&gt; The yield of 70% ethanol extract (11.24%) was higher than the aqueous extract (7.29%). The phytochemical screening on the simplicia and the two extracts positively contained steroids, flavonoids, saponins, and tannins. The optimum conditions of XO activity were temperature of 20 ℃, pH of 8.0, and xanthine concentration of 1.40 mM. The toxicity of the 70% ethanol extract (LC&lt;sub&gt;50&lt;/sub&gt; 662.25 mg/L) was stronger than the aqueous extract (LC&lt;sub&gt;50&lt;/sub&gt; 774.68 mg/L). Moreover, the 70% ethanol extract (IC&lt;sub&gt;50 &lt;/sub&gt;224.14±8.62 mg/L) showed higher XO inhibition than the water extract (IC&lt;sub&gt;50&lt;/sub&gt; 348.83±4.85 mg/L). Lineweaver-Burk plot analysis showed that 70% ethanol and water extracts inhibited XO competitively with the inhibition constant (KI) of 272.68 mg/L and 378.44 mg/L, respectively. &lt;strong&gt;Conclusion:&lt;/strong&gt; This preliminary study can be a reference that &lt;em&gt;S. littoralis&lt;/em&gt; Hassk. is potentially an antigout.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article </style></work-type><section><style face="normal" font="default" size="100%">258</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Min Rahminiwati&lt;sup&gt;1,3,*&lt;/sup&gt;, Rut Novalia Rahmawati Sianipar&lt;sup&gt;2&lt;/sup&gt;, Komar Sutriah&lt;/strong&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;strong&gt;, Dyah Iswantini&lt;sup&gt;2,3,*&lt;/sup&gt;, Trivadila&lt;sup&gt;2,3&lt;/sup&gt;, Suminar Setiati Achmadi&lt;sup&gt;2,3&lt;/sup&gt;, Ibnu Hari Sulistyawan&lt;sup&gt;4&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Anatomy, Physiology, and Pharmacology, Veterinary Medicine and Biomedical School, IPB University, Bogor 16680, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Chemistry, Faculty of Mathematics and Natural Sciences, IPB University, Bogor 16680, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Tropical Biopharmaca Research Center, IPB University, Bogor 16128, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Laboratory of Poultry Production, Faculty of Animal Science, Jenderal Soedirman University, Purwokerto 53122, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Min Rahminiwati</style></author><author><style face="normal" font="default" size="100%">Trivadila</style></author><author><style face="normal" font="default" size="100%">Dyah Iswantini</style></author><author><style face="normal" font="default" size="100%">Hiroshi Takemori</style></author><author><style face="normal" font="default" size="100%">Mamoru Koketsu</style></author><author><style face="normal" font="default" size="100%">Rut Novalia Rahmawati Sianipar</style></author><author><style face="normal" font="default" size="100%">Suminar Setiati Achmadi</style></author><author><style face="normal" font="default" size="100%">Ahmad Sjahriza</style></author><author><style face="normal" font="default" size="100%">Betty Marita Soebrata</style></author><author><style face="normal" font="default" size="100%">Armi Wulanawati</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Indonesian Medicinal Plants with Anti-inflammatory Properties and Potency as Chronic Obstructive Pulmonary Disease (COPD) Herbal Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-inflammatory</style></keyword><keyword><style  face="normal" font="default" size="100%">Bioactive compounds</style></keyword><keyword><style  face="normal" font="default" size="100%">Biological activity</style></keyword><keyword><style  face="normal" font="default" size="100%">Chronic obstructive pulmonary disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesian medicinal plants</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">432-444</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Indonesia is a tropical country with mega-biodiversity. Several medicinal plants locally have been recognized for their anti-inflammatory properties and are traditionally used to help treat respiratory diseases. Chronic obstructive pulmonary disease (COPD) is one of the diseases known as the high cause of death globally, and one of the treatment efforts is by using anti-inflammatory drugs. In developing alternative remedies for COPD, this review summarizes the potential of Indonesian medicinal plants and their ingredients known to have an anti-inflammatory activity to develop alternative remedies for COPD. Primarily, we focus on the medicinal plants that have been scientifically proven to pose some biological activities, such as legetan warak (&lt;em&gt;Adenostemma lavenia&lt;/em&gt;), celery &lt;em&gt;(Apium graveolens&lt;/em&gt;),&lt;em&gt; pegagan&lt;/em&gt; (&lt;em&gt;Centella asiatica&lt;/em&gt;),&lt;em&gt; kenikir &lt;/em&gt;(&lt;em&gt;Cosmos caudatus&lt;/em&gt;), and &lt;em&gt;kersen (Muntingia calabura). &lt;/em&gt;This review is expected to provide more information about Indonesian medicinal plants and their potencies to be developed as COPD herbal medicine and, further, as a treatment to help patients suffering from coronavirus disease (COVID-19).&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><accession-num><style face="normal" font="default" size="100%">26</style></accession-num><section><style face="normal" font="default" size="100%">432</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Min Rahminiwati&lt;sup&gt;1,4,*&lt;/sup&gt;, Trivadila&lt;sup&gt;2,4&lt;/sup&gt;, Dyah Iswantini&lt;sup&gt;2,4&lt;/sup&gt;,*, Hiroshi Takemori&lt;sup&gt;3&lt;/sup&gt;, Mamoru Koketsu&lt;sup&gt;3&lt;/sup&gt;, Rut Novalia Rahmawati Sianipar&lt;sup&gt;2&lt;/sup&gt;, Suminar Setiati Achmadi&lt;sup&gt;2,4&lt;/sup&gt;, Ahmad Sjahriza&lt;sup&gt;2&lt;/sup&gt;, Betty Marita Soebrata&lt;sup&gt;2&lt;/sup&gt;, Armi Wulanawati&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Anatomy, Physiology, and Pharmacology, Faculty of Veterinary Medicine, IPB University, Bogor 16680, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Chemistry, Faculty of Mathematics and Natural Sciences, IPB University, Bogor 16680, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, 1-1 Yanagido, Gifu 501-1193, JAPAN.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Tropical Biopharmaca Research Center, IPB University, Bogor 16128, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rut Novalia Rahmawati Sianipar</style></author><author><style face="normal" font="default" size="100%">Komar Sutriah</style></author><author><style face="normal" font="default" size="100%">Dyah Iswantini</style></author><author><style face="normal" font="default" size="100%">Suminar Setiati Achmadi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Inhibitory Capacity of Xanthine Oxidase in Antigout Therapy by Indonesian Medicinal Plants</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Competitive inhibition kinetics</style></keyword><keyword><style  face="normal" font="default" size="100%">Flavonoid</style></keyword><keyword><style  face="normal" font="default" size="100%">Gout</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesia</style></keyword><keyword><style  face="normal" font="default" size="100%">Xanthine Oxidase</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">470-479</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;The traditional medicine has been used in Indonesia since the days of the Ancient Mataram Kingdom (about 12 centuries ago). Indonesia is rich in medicinal plants. For this reason, it is necessary to inform the broader community regarding medicinal plants in Indonesia that have the potential as antigout. The prevalence of gout in Indonesia is in the range of 1.6−13.6 per 100,000 people and will increase with age. There are 25 species of Indonesian plants that have more than 50% xanthine oxidase (XO) enzyme inhibitory activity. XO is responsible for catalyzing hypoxanthine to xanthine then producing uric acid, accompanied by the formation of reactive oxygen species (ROS) during catalysis. The magnitude of the inhibitory power to XO ranged from 50.00±1.16% to 97.53%. The lowest inhibitory power of 50.00±1.16% was in &lt;em&gt;Phaleria macrocarpa,&lt;/em&gt; while Orthosiphon aristatus had the highest inhibitory power of 97.53%. The major compounds that inhibit xanthine oxidase are flavonoids. The structural similarity of flavonoids in rings A and C with xanthine as a substrate causes hydrophobic interactions, hydrogen bonds, and van der Waals forces between flavonoids and XO. It means that flavonoids bind to the XO active site, thereby preventing the formation of uric acid. The type of inhibitory kinetics that occurs between flavonoids and XO is competitive inhibition. Five plants with competitive inhibition kinetics against XO are&lt;em&gt; Sida rhombifolia, Syzygium polyanthum, Cyperus rotundus, Ruellia tuberosa &lt;/em&gt;and &lt;em&gt;Phaleria macrocarpa.&lt;/em&gt;&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">470</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Rut Novalia Rahmawati Sianipar&lt;sup&gt;1&lt;/sup&gt;, Komar Sutriah&lt;sup&gt;1,*&lt;/sup&gt;, Dyah Iswantini&lt;sup&gt;1,2,*&lt;/sup&gt;, Suminar Setiati Achmadi&lt;/strong&gt;&lt;sup&gt;&lt;strong&gt;1,2&lt;/strong&gt; &lt;/sup&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Chemistry, Faculty of Mathematics and Natural Sciences, IPB University, Bogor 16680, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Tropical Biopharmaca Research Center, IPB University, Bogor 16128, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>